Hematological Toxicity of Immune Checkpoint Inhibitors: Real-World Retrospective Outcomes from a Cohort Study in Qatar

被引：1

作者：

Benkhadra, Maria ^{[1
]}

Elazzazy, Shereen ^{[1
]}

Hamad, Anas Ahmad ^{[1
]}

Elkhatim, Mohamed S. ^{[2
]}

Gulied, Amaal ^{[1
]}

Sahal, Arwa Osama ^{[1
]}

Alasmar, Aya ^{[1
]}

Jibril, Farah I. ^{[1
]}

Afifi, Hebatalla Mahmoud ^{[1
]}

Nasser, Sahar ^{[1
]}

Alnajjar, Afnan ^{[1
]}

Dawoud, Rawan ^{[1
]}

Omar, Nabil E. ^{[1
,3
]}

机构：

[1] Hamad Med Corp, Dept Pharm, Natl Ctr Canc Care & Res, Doha, Qatar

[2] Hamad Med Corp, Dept Med Oncol, Natl Ctr Canc Care & Res, Doha, Qatar

[3] Qatar Univ, Coll Pharm, Clin & Populat Hlth Res, Doha, Qatar

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180648

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms: retrospective data from real-world settings
Kapoor, Akhil
Noronha, Vanita
Patil, Vijay M.
Joshi, Amit
Menon, Nandini
Mahajan, Abhishek
Janu, Amit
Prabhash, Kumar
ECANCERMEDICALSCIENCE, 2020, 14
[42] Immune checkpoint inhibitors in the treatment of pleural mesothelioma: insights from real-world data
Kanayama, Masatoshi
Manabe, Takehiko
Yoshimatsu, Katsuma
Oyama, Rintaro
Matsumiya, Hiroki
Mori, Masataka
Takenaka, Masaru
Kuroda, Koji
Tanaka, Fumihiro
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025, : 705 - 717
[43] From clinical trials to real-world practice: Immune checkpoint inhibitors in older adults
Loh, Kah Poh
Wong, Melisa L.
Maggiore, Ronald
JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (03) : 385 - +
[44] BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience
Rihawi, Karim
Giannarelli, Diana
Galetta, Domenico
Delmonte, Angelo
Giavarra, Marco
Turci, Daniele
Garassino, Marina
Tiseo, Marcello
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : E57 - E59
[45] Adverse drug events of immune checkpoint inhibitors - Preliminary results of a retrospective real-world data analysis
Auch, L.
Hug, B.
SWISS MEDICAL WEEKLY, 2024, 154 : 19S - 19S
[46] Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma
Bol, K. F.
Ellebaek, E.
Donia, M.
Schmidt, H.
Bastholt, L.
Kiilgaard, J. F.
Svane, I-M.
ANNALS OF ONCOLOGY, 2019, 30 : 539 - 539
[47] Immune Checkpoint Inhibitors for Nasopharyngeal Carcinoma in a Real-world Setting in Japan
Manako, Tomomi
Yasumatsu, Ryuji
Nakano, Takafumi
Matsuo, Mioko
Takeuchi, Toranishin
Taura, Masahiko
Tamae, Akihiro
Yamauchi, Moriyasu
Masuda, Muneyuki
Taguchi, Kenichi
Nakagawa, Takashi
IN VIVO, 2023, 37 (02): : 747 - 755
[48] Real-world safety experience with immune checkpoint inhibitors in Saudi Arabia
Al Nuhait, Mohammed
Bajnaid, Eshtyag
Al Otaibi, Abdulmalik
Al Shammari, Abdullah
Al Awlah, Yousef
SCIENCE PROGRESS, 2021, 104 (01)
[49] Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
Bol, Kalijn Fredrike
Ellebaek, Eva
Hoejberg, Lise
Bagger, Mette Marie
Larsen, Mathilde Skaarup
Klausen, Tobias Wirenfeldt
Kohler, Ulrich Heide
Schmidt, Henrik
Bastholt, Lars
Kiilgaard, Jens Folke
Donia, Marco
Svane, Inge Marie
CANCERS, 2019, 11 (10)
[50] OUTCOMES IN PATIENTS WITH PRE-EXISTING AUTOIMMUNE DISEASES WHO RECEIVED IMMUNE CHECKPOINT INHIBITORS: A REAL-WORLD STUDY
Pavlick, Anna
Palaia, Jennell
Pisupati, Radhika
Fu, Benjamin
Wittstock, Keith
Zhang, Ying
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A461 - A461

← 1 2 3 4 5 →